ARG1 and neoplasm: In contrast, 40–60% of Ly6G+ intermediate cells and 5–11% of Ly6G− and Ly6G+ high cells were positive for ARG1 in 66cl4 tumours, suggesting that ARG1 is a marker for a subpopulation of myeloid cells with intermediate Ly6G expression.